Optimizing the Outcome of Anti-Myeloma Treatment with Daratumumab
A search of the scientific literature for <i>Daratumumab</i> and <i>myeloma</i> gives more than 600 results (January 2021), which reflects the interest and activity around this antibody, an interest that was also reflected by the assignment of breakthrough designation for Dar...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-03-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/10/5/1002 |